Navigation Links
Xenome Enters Into Joint Research Collaboration to Discover Novel Peptide Therapeutics with Amylin Pharmaceuticals
Date:11/27/2007

BRISBANE, Australia, Nov. 27 /PRNewswire/ -- Xenome Ltd., a leader in developing unique peptides for therapeutic applications in a variety of diseases, today announced the signing of a joint research collaboration agreement with Amylin Pharmaceuticals, Inc. The partnership will focus on the discovery and development of novel peptide therapeutics for a range of metabolic and musculoskeletal diseases.

In addition to the joint research collaboration agreement, Amylin has made an equity investment in Xenome matched by investments from Queensland BioCapital Funds and Innovis Australia.

Under the collaboration, Amylin will apply its proprietary screening technologies to evaluate the therapeutic potential of the peptides from Xenome's proprietary bioactive peptide library derived from natural sources. Amylin will have the right to select and exclusively license lead candidates resulting from a screening program in metabolic and musculoskeletal disease for further development and commercialization in exchange for milestone payments and royalties payable to Xenome.

"This collaboration with Amylin is an important strategic move for Xenome as it provides us with funding, and the ability to leverage our peptide chemistry capabilities in a therapeutic area outside of Xenome's current focus." commented Xenome's CEO Lewis Lee. "Amylin's research organization has successfully created several peptide therapies for the treatment of diabetes and potentially obesity."

"We are pleased to be working with Xenome," said Michael Hanley, Ph.D., Vice President, Discovery Research at Amylin. "Amylin is committed to bringing innovative medicines with life-changing therapeutic potential to patients. This mutually beneficial collaboration combines Xenome's proprietary peptide library with Amylin's therapeutic expertise and creates valuable opportunities to discover and develop novel therapeutics."

To date, Xenome's focus has been in the discovery and deve
'/>"/>

SOURCE Xenome
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Dana Corporation, Inc. Enters Into Settlement Agreement With Dana Retiree Committee
2. PainCare Receives $14.4 Million in Cash From Completed Sale of South Florida Ambulatory Surgery Centers
3. Atlanta Falcons Physical Therapy Centers Set to Launch This Fall
4. Navitas Opens New Cancer Rehabilitation Center in Albuquerque in Conjunction With New Mexico Cancer Centers
5. Medicare Prescription Drug Benefit, Nonprofit Hospitals, Ambulatory Surgery Centers, Statistical Methods, and Pay-For-Performance Highlighted In the Latest INQUIRY Journal
6. Service-to-Sales Transformation at Contact Centers Hinges on Soft Skills
7. The First Incisionless Transoral Fundoplication for Treatment of Gastroesophageal Reflux is Performed in the U.S. at Ohio State University and Oregon Health & Science University Medical Centers
8. Community Health Centers Reveal Specific Ramifications of The Medicaid Citizenship and Identification Documentation Requirements
9. Commercial Insurers Reimbursement Rate to New Yorks Community Health Centers Jeopardizes Care
10. Pennsylvania Trauma Systems Foundation Accreditation Status for Trauma Centers
11. Vangent, Inc. Wins Spot on Centers for Medicare & Medicaid Services Enterprise System Development Contract
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... diabetic peripheral neuropathy is important for the successful ... Fourth Affiliated Hospital of Kunming Medical University, China, ... a sensitive index for nerve conduction studies in ... patients with diabetes mellitus. Nerve conduction studies revealed ... conduction velocity was slower, and sensory nerve action ...
(Date:8/21/2014)... Bedros Keuilian’s Annual Fitness Business Summit is ... by many people already earning seven-figure incomes. But his annual ... only open to the owners of Keuilian’s own international fitness ... Fit Body Boot Camp World Conference will also be attended ... boot camp or are struggling with their own boot ...
(Date:8/21/2014)... (PRWEB) August 21, 2014 Quantum ... are pleased to announce the healthcare technology platform, ... operational/production servers. , The company anticipates provisioning its ... are established between individual physicians, via interfaces, to medical ... and finally with electronic data exchanges and medical clearing ...
(Date:8/21/2014)... August 21, 2014 Australian scientists say ... Staph bacteria has been used to successfully fight mesothelioma ... article on the new research. Click here to ... of Western Australia treated mesothelioma cells with ... the cancer cells while simultaneously stimulating a stronger anti-tumor ...
(Date:8/21/2014)... B. E. Smith, the only full-service leadership solutions ... to lead a national Chief Nurse Executive ... in Valdosta, GA. The top executive search firm ... recently placed more than 900 healthcare executives into organizations. ... organization headquartered in Valdosta, GA., and its four campuses ...
Breaking Medicine News(10 mins):Health News:Fitness Boot Camp Founder Offers Fifty Scholarships to Fit Body Boot Camp World Conference 2Health News:Fitness Boot Camp Founder Offers Fifty Scholarships to Fit Body Boot Camp World Conference 3Health News:Grace Century’s Electronic Health Records Project, Quantum Innovations, Announces That PWeR® Healthcare Technology Platform is Ready for Deployment 2Health News:Grace Century’s Electronic Health Records Project, Quantum Innovations, Announces That PWeR® Healthcare Technology Platform is Ready for Deployment 3Health News:Grace Century’s Electronic Health Records Project, Quantum Innovations, Announces That PWeR® Healthcare Technology Platform is Ready for Deployment 4Health News:Study Finds Bacteria Compound Shrinks Mesothelioma Tumors, According to Surviving Mesothelioma 2Health News:South Georgia Medical Center Retains B. E. Smith to Recruit New Chief Nurse Executive 2Health News:South Georgia Medical Center Retains B. E. Smith to Recruit New Chief Nurse Executive 3
... trials in humans to treat obesity from a drug derived ... the Managing Director of the company. ,As per ... and each part of the plant has a different effect ... has the power to curb hunger, some other part of ...
... who wear a special kind of no-line bifocal lenses ... who wear more conventional lenses according to a new// ... Ophthalmology & Visual Science (IOVS). ,The ... myopia progression was slower in children wearing progressive-addition lenses ...
... February is National Children's Dental Health Month and as ... its Fifth Annual Give Kids A Smile Day on ... the ADA offers advice for parents and caregivers to ... ,"Preventive dental care has greatly improved the oral health ...
... pill-sized robot that can travel inside your body, can find ... to a computer//. ,After being swallowed, the robot ... Daily Mail. The miniature video camera fitted with the device ... ,The extraordinary invention by Alex Zivanovic of Imperial College, London, ...
... be bustling around hospital wards in as little as ... developed ground-breaking software//. ,The mechanised "nursebots" being ... such as mopping up spillages, taking messages and guiding ... distribute medicines and even monitor the temperature of patients ...
... if its treatment guidelines are followed, the death rate in ... 5%, but it is more common for 20% or over ... the deaths of 1.5 million children every year. ... Professor of Paediatrics in Blantyre, Malawi discusses whether the problem ...
Cached Medicine News:Health News:Good Oral Health Practices Should Begin in Infancy 2Health News:Robot Nurses Ready For Hospitals 'In Three Years' 2
(Date:8/21/2014)... WOONSOCKET, R.I. , Aug. 21, 2014 CVS ... early tender results, applicable Reference Yields and consideration payable in ... Offers") commenced on August 7, 2014 for (1) any and ... and All Notes") and (2) up to a maximum amount ... due 2041 and 5.750% Senior Notes due 2017 (collectively, the ...
(Date:8/21/2014)... ANDOVER, Mass. , Aug. 21, 2014 /PRNewswire/ ... AEX: PHIA) today announced it has received ... Administration to market its precision planning application for ... the Philips TAVI application provides interventionalists with pre-procedural, ... The Philips TAVI planning application is available ...
(Date:8/21/2014)... 2014   Auxilium Pharmaceuticals, Inc. (NASDAQ: ... today announced positive results from a randomized, double-blind ... CCH) for the treatment of edematous fibrosclerotic panniculopathy ... 2a trial, all three doses of CCH (low ... improvement in the appearance of cellulite as measured ...
Breaking Medicine Technology:CVS Caremark Corporation Announces Early Results of Tender Offers, Pricing, Election of Early Settlement and Increase in the Maximum Tender Offer Amount 2CVS Caremark Corporation Announces Early Results of Tender Offers, Pricing, Election of Early Settlement and Increase in the Maximum Tender Offer Amount 3CVS Caremark Corporation Announces Early Results of Tender Offers, Pricing, Election of Early Settlement and Increase in the Maximum Tender Offer Amount 4CVS Caremark Corporation Announces Early Results of Tender Offers, Pricing, Election of Early Settlement and Increase in the Maximum Tender Offer Amount 5CVS Caremark Corporation Announces Early Results of Tender Offers, Pricing, Election of Early Settlement and Increase in the Maximum Tender Offer Amount 6Philips receives FDA 510(k) Clearance for TAVI Precision Treatment Planning Application 2Philips receives FDA 510(k) Clearance for TAVI Precision Treatment Planning Application 3Auxilium Pharmaceuticals, Inc. Announces Positive Data From Phase 2a Study Of CCH In Patients With Cellulite 2Auxilium Pharmaceuticals, Inc. Announces Positive Data From Phase 2a Study Of CCH In Patients With Cellulite 3Auxilium Pharmaceuticals, Inc. Announces Positive Data From Phase 2a Study Of CCH In Patients With Cellulite 4Auxilium Pharmaceuticals, Inc. Announces Positive Data From Phase 2a Study Of CCH In Patients With Cellulite 5Auxilium Pharmaceuticals, Inc. Announces Positive Data From Phase 2a Study Of CCH In Patients With Cellulite 6Auxilium Pharmaceuticals, Inc. Announces Positive Data From Phase 2a Study Of CCH In Patients With Cellulite 7
Our soft guedel airway is clear and has a color coded bite block. Airway has a smooth finish and is Latex Free. Recommended for single use. Non-Sterile....
New - Color Coded Berman Airways. A simple idea makes size identification easier for you., ,Premium upgrade without a premium price. Color Coded Berman airways are latex-free., ,Plastic. Single use...
... Endotracheal Tube Kits (silicone) Magill, ... includes a SidePort™ AutoControl™ airway connector, ... mm ISO connector., ,The wire ... helping to ensure an open airway., ...
... Portex® Blue Line® uncuffed ... Magill or Murphy styles, in ... ,Blue Line® adult and pediatric ... from implant-tested polyvinyl chloride with ...
Medicine Products: